NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/06/2022
Back to search
Official data from USPTO
PRIONRX SCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PRIONRX SCIENCE
ST13
US500000090541303Class
44
Filing
90541303
Registration
6840498
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
09/06/2022
Trademark type
Word
Nice classes
44
Filing date
02/23/2021
Registration date
09/06/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/06/2022
Last transaction
09/06/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/20/2022
First use in commerce
06/20/2022
Drawing code
4
Owner type
03
Owner location
San Francisco, CA
Examiner
HESIK, APRIL
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Amprion, Inc.
Representatives
Benjamen E. Kern KERN KENDRICK, LLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical diagnosis of neurodegenerative diseases
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/06/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/04/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/30/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/29/2022
EX1G
SOU EXTENSION 1 GRANTED
07/29/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/28/2022
IUAF
USE AMENDMENT FILED
07/13/2022
EISU
TEAS STATEMENT OF USE RECEIVED
07/13/2022
NREV
NOTICE OF REVIVAL - E-MAILED
07/13/2022
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
07/13/2022
PETG
PETITION TO REVIVE-GRANTED
07/13/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
07/13/2022
EXT1
SOU EXTENSION 1 FILED
07/11/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/16/2021
PUBO
PUBLISHED FOR OPPOSITION
11/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/20/2021
GNRT
NON-FINAL ACTION E-MAILED
09/20/2021
CNRT
NON-FINAL ACTION WRITTEN
09/20/2021
DOCK
ASSIGNED TO EXAMINER
09/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/24/2021
NWAP
NEW APPLICATION ENTERED
02/26/2021
Continuous trademark protection
Get notified about every new filing that threatens PRIONRX SCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.